Patent Reform: 2011-2012
Obama administration officials moved to assuage American inventors’ fears Tuesday that a fundamental change being sought in the nation’s patent system won’t put them at a disadvantage.
The patent system in US hasn’t changed much since 1952 when Sony was coming out with its first pocket-size transistor radio, and bar codes.
“The first to file system is simpler, which enhances property rights in the innovation marketplace by providing greater legal certainty for small businesses, and the first inventor to file system of course requires proof that an applicant was the first inventor to file, meaning an inventor, and would not inside of a blind range of the patent office that would in any way disadvantage small businesses.” said Davis Kapoos.
The Senate is taking up the Patent Reform Act, which would significantly overhaul a 1952 law and, supporters say, bring the patent system in line with 21st century technology of biogenetics and artificial intelligence.
There are about 1.2 million applications pending-700,000 waiting consideration and another 500,000 somewhere in the process. The patent office says it received about 483,000 applications in 2009 and granted about 192,000 patents.
“This bill, if we do it right, will create millions of new jobs,” Senate Majority Leader Harry Reid, a Nevada Democrat, said Tuesday on the Senate floor.
Future’s Technology Going on the Auction Block
ICAP Ocean Tomo is the intellectual property brokerage division of ICAP and the world’s premier patent auction firm.
Some of the fascinating patented technologies like Improved airport detection systems, a new osteoporosis treatment, advanced high-performance building materials, superplastic aluminum alloys, lower-cost magnetic therapies for treating cancer and tumors, and a centralized control box to help smart houses coordinate appliances will be featured at the world’s premiere live IP auction – the ICAP Ocean Tomo Spring 2011 Live IP Auction. These technologies and other featured patents will be of interest to a whole range of industries, from medicine and construction, to consumer electronics and homeland security.
This event brings together business and technology leaders from the world’s leading IP companies. Attendees will include representatives from universities, federal labs, law and venture capital firms, and business leaders from the companies interested in the potential of these cutting-edge technologies.
The auction will be held Thursday, March 31st in New York City at Capitale beginning at 1:00 PM.
EPO has granted three core patents to Caprotec
Caprotec announced today that the European Patent Office has granted the last of three core patents protecting its proprietary and revolutionary Capture Compound Mass Spectrometry (CCMS) technology.
The newly granted European Patent No. EP 1583972 titled “Methods for Identifying Drug Non-targets” covers the use of CCMS technology for lead optimization and risk assessment of candidate drugs to make a go or no-go decision to enter the clinical trial phase. The European Patent No. EP 1485707 titled “Compounds and Methods for Analyzing the Proteome” covers Capture Compounds and methods to discover protein biomarkers for diagnostic applications. European Patent No. EP 1502102 titled “Compounds and Methods for Analyzing the Proteome” covers an array-based application of CCMS technology. Equivalent patents have been issued in many major countries.
Agilent acquires Lab901
Agilent Technologies Inc. announced it has acquired Lab901, a leading electrophoresis equipment and consumables company based in U.K. The company’s automated electrophoresis products are used for DNA, RNA and protein analysis. Financial details of the acquisition were not disclosed.